surgumedВестник СурГУ. МедицинаVestnik SurGU. Meditsina2949-3447Сургутский государственный университетsurgumed-241Research ArticleПРОФИЛАКТИЧЕСКАЯ МЕДИЦИНА. ОБЗОР ЛИТЕРАТУРЫPREVENTIVE MEDICINE. REVIEWSМУЛЬТИМОРБИДНОСТЬ КАК ПРОБЛЕМА ПРИВЕРЖЕННОСТИ К ЛЕЧЕНИЮ И ПРОГНОЗА У ПАЦИЕНТОВ С ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМMULTIMORBIDITY AS COMPLIANCE TO TREATMENT AND PROGNOSIS PROBLEM IN PATIENTS WITH ACUTE CORONARY SYNDROMEПолтаранинаВ. А.PoltaraninaV. A.

аспирант кафедры кардиологии, Медицинский институт

Postgraduate, Department of Cardiology, Medical Institute

КашталапВ. В.KashtalapV. V.

доктор медицинских наук, доцент, заведующий лабораторией патофизиологии мультифокального атеросклероза, профессор кафедры кардиологии, Медицинский институт

Doctor of Science (Medicine), Associate Professor, Head, Laboratory of Pathophysiology Department of Multifocal Atherosclerosis, Kemerovo; Professor, Department of Cardiology, Medical Institute

ВоробьевА. С.VorobyevA. S.

кандидат медицинских наук, доцент кафедры кардиологии, ведущий научный сотрудник научно-образовательного центра, Медицинский институт

PhD (Medicine), Assistant Professor, Department of Cardiology, Leading Researcher, Research and Educational Center, Medical Institute

УрванцеваИ. А.UrvantsevaI. A.

кандидат медицинских наук, доцент, заведующий кафедрой кардиологии, Медицинский институт

PhD (Medicine), Associate Professor, Head, Department of Cardiology, Medical Institute,

Сургутский государственный университетРоссияSurgut State UniversityRussian FederationНаучно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний, г. Кемерово, Сургутский государственный университетРоссияResearch Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Surgut State UniversityRussian Federation20192309201903 (41)4450Copyright © Полтаранина В.А., Кашталап В.В., Воробьев А.С., Урванцева И.А., 20192019Полтаранина В.А., Кашталап В.В., Воробьев А.С., Урванцева И.А.Poltaranina V.A., Kashtalap V.V., Vorobyev A.S., Urvantseva I.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.surgumed.ru/jour/article/view/241мультиморбидностькоморбидностьострый коронарный синдромприверженность к лечениюпрогноз.multimorbiditycomorbidityacute coronary syndromecomplianceprognosis.ReferencesНургазизова А. К. Происхождение, развитие и современная трактовка понятий «коморбидность» и «полиморбидность» // Казан. мед. журн. 2014. Т. 95, № 2. С. 292–296.Nurgazizova A.K. Origin, Development and Modern Interpretation of the Terms “Comorbidity” and “Multimorbidity” // Kazan Medical Journal. 2014.Feinstein A. The Pre-Therapeutic Classification of Co-Morbidity in Chronic Disease // J Chron Dis. 1970. № 23. P. 455–469.No. 95 (2). P. 292–296. (In Russian).Насонов Е. Л., Гардеев А. В., Галушко Е. А. Ревматические заболевания и мультиморбидность // Терапевтич. архив. № 5. 2015. С. 4–9.Feinstein A. The Pre-Therapeutic Classification of Co-Morbidity in Chronic Disease. // J Chron Dis. 1970. No. 23. P. 455–469.Van den Bussche H., Schön G., Kolonko T., Hansen H., Wegscheider K., Glaeske G., Koller D. Patterns of Ambulatory Medical Care Utilization in Elderly Patients with Special Reference to Chronic Diseases and Multimorbidity – Results from a Claims Data Based Observational Study in Germany // BMC Geriatr. 2011. P. 11–54.Nasonov E. L., Gardeev A. V., Galushko E. A. Reumatic Diseases and Multimorbidity // Therapeutic Archive. No. 5. 2015. P. 4–9. (in Russian).Boyd C. M., Fortin M. Future of Multimorbidity Research: How Should Understanding of Multimorbidity Inform Health System Design? // Public Health Reviews. 2011. № 32 (2). P. 451–474.Van den Bussche H., Schön G., Kolonko T., Hansen H., Wegscheider K., Glaeske G., Koller D. Patterns of Ambulatory Medical Care Utilization in Elderly Patients with Special Reference to Chronic Diseases and Multimorbidity – Results from a Claims Data Based Observational Study in Germany // BMC Geriatr. 2011. P.11–54.Ширинский В. С., Ширинский И. В. Коморбидные заболевания – актуальная проблема клинической медицины // Сиб. мед. журн. 2014. Т. 29, № 1. С. 7–12.Boyd C. M., Fortin M. Future of Multimorbidity Research: How Should Understanding of Multimorbidity Inform Health System Design? // Public Health Reviews. 2011. No. 32 (2). P. 451–474.Барбараш О. Л., Кашталап В. В. Двойная антитромбоцитарная терапия у пациентов с острым коронарным синдромом. Результаты реальной клинической практики // Рос. кардиолог. журн. 2018. Т. 23, № 10. С. 27–35.Shirinskiy V. S., Shirinskiy I. V. Comorbid Diseases – Actual Problem of Clinical Medicine // Siberian Medical Journal. 2014. No. 29 (1). P. 7–12. (In Russian).Mokraoui N. M., Haggerty J., Almirall J., Fortin M. Prevalence of Self-Reported Multimorbidity in the General Population and in Primary Care Practices: a Cross-Sectional Study // BMC Research Notes. 2016. № 9. P. 314.Barbarash O. L., Kashtalap V. V. Double Antithrombotic Therapy in Patients with Acute Coronary Syndrome. Results of the Real Clinical Practice // RussianButtorff C., Ruder T., Bauman M. Multiple Chronic Conditions in the United States. Santa Monica : RAND Corporation, 2017. 33 p.Journal of Cardiology. 2018. No. 23 (10). P. 127–135. (In Russian).Кушникова И. П., Граудина В. Е. Сердечно-сосудистая патология у больных хронической обструктивной болезнью легких: клинико-патогенетические особенности и диагностика // ВестникMokraoui N. M., Haggerty J., Almirall J., Fortin M. Prevalence of Self-Reported Multimorbidity in the General Population and in Primary Care Practices: aСурГУ. Медицина. 2019. № 1. С. 8–13.Cross-Sectional Study // BMC Research Notes. 2016. No. 9. P. 314.Salive M. E. Multimorbidity in Older Adults // Epidemiologic Reviews. 2013. № 35. P. 75–83.Buttorff C., Ruder T., Bauman M. Multiple Chronic Conditions in the United States. Santa Monica: RAND Corporation, 2017. 33 p.Kingston A., Robinson L., Booth H., Knapp M., Jaggerfor C. Projections of Multi- Morbidity in the Older Population in England to 2035: Estimates from the Population Ageing and Care Simulation (PACSim) Model // Age Ageing, 2018. P. 1–7.Kushnikova I. P., Graudina V. E. Сardiovascular Pathology in Patients with Chronic Obstructive Pulmonary Disease: Clinical and Pathogenetic Features and DiagnosticsCaughey G. E., Vitry A. I., Gilbert A. L., Roughead E. E. Prevalence of Comorbidity of Chronic Diseases in Australia // BMC Public Health. 2008. № 8. P. 221.// Vestnik SurGU. Medicina. 2019. No. 1. P. 8–13. (In Russian).Charlson M. E., Pompei P., Ales H. L. A New Method of classifying Prognostic Comorbidity in Longitudinal Studies: Development and Validation // Journal Chronic Disease. 1987. № 40. P. 373–383.Salive M. E. Multimorbidity in Older Adults // Epidemiologic Reviews. 2013. No. 35.Журавлев Ю. И., Тхорикова В. Н. Современные проблемы измерения полиморбидности // Науч. ведомости БелГУ. Сер. Медицина. Фармация. 2013. Т. 11 (154), № 22. С. 214–219.P. 75–83.Clark D. O., Von Korff M., Saunders K., Baluch W. M., Simon G. E.: A Chronic Disease Score with Empirically Derived Weights // Med Care. 1995. № 33 (8). P. 783–795.Kingston A., Robinson L., Booth H., Knapp M., Jaggerfor C. Projections of Multi- Morbidity in the Older Population in England to 2035: Estimates from the Population Ageing and Care Simulation (PACSim) Model // Age Ageing. 2018. No. 0. P. 1–7.Fishman P. A., Goodman M. J., Hornbrook M. C., Meenan R. T., Bachman D. J., O’Keeffe Rosetti M. C. Risk Adjustment Using Automated Ambulatory Pharmacy Data: the RxRisk Model // Med Care. 2003. № 41 (1). P. 84–99.Caughey G. E., Vitry A. I., Gilbert A. L., Roughead E. E. Prevalence of Comorbidity of Chronic Diseases in Australia // BMC Public Health. 2008. No. 8. P. 221.De Groot V., Beckerman H., Lankhorst G. J., Bouter L. M. How to Measure Comorbidity: a Critical Review of Available Methods // J Clin Epidemiol. 2003. № 56 (3). P. 221–229.Charlson M. E., Pompei P., Ales H. L. A New Method of Classifying Prognostic Comorbidity in Longitudinal Studies: Development and Validation // Journal Chronic Disease. 1987. No. 40. P. 373–383.Коморбидная патология в клинической практике : клинич. рек. // Кардиоваскулярная терапия и профилактика. 2017. № 16 (6).Zhuravlev Yu. I., Tkhorikova V. N. Modern Problems of Multimorbidity Measurement // Scientific News BelSU. Medicine Series. Farmacy. 2013. No. 11 (154). Vol. 22. P. 214–219. (In Russian).С. 5–56.Clark D. O., Von Korff M., Saunders K., Baluch W. M., Simon G. E.: A Chronic Disease Score with Empirically Derived Weights // Med Care. 1995. No. 33 (8). P. 783–795.Vedanthan R., Seligman B., Fuster V. Global Perspective on Acute Coronary Syndrome: a Burden on the Young and Poor // Circulation Reserch. 2014. № 114 (12). P. 1959–1975.Fishman P. A., Goodman M. J., Hornbrook M. C., Meenan R. T., Bachman D. J., O’Keeffe Rosetti M.C. Risk Adjustment Using Automated Ambulatory Pharmacy Data: the RxRisk Model // Med Care. 2003. No. 41 (1). P. 84–99.Guiding Principles for the Care of Older Adults with Multimorbidity: an Approach for Clinicians. American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity // J Amer Ger Soc. 2012. № 60 (10). P. E1–E25.De Groot V., Beckerman H., Lankhorst G. J., Bouter L. M. How to Measure Comorbidity: a Critical Review of Available Methods // J Clin Epidemiol. 2003. No. 56Rothwell P. M. External Validity of Randomised Controlled Trials: to whom do the Results of This Trial Apply? // Lancet. 2005. № 365.(3). P. 221–229.P. 82–93.Oganov R. G., Denisov I. N., Simanenkov V. I., Bakulin I. G., Bakulina N. V., Boldueva S. A., Barbarash O. N., Garganeeva N. P., Doshchitsin V. L., Drapkina O. M., Dudinskaia E. N., Kotovskaia Yu. V., Lila A. M., Mamedov M. N., Mardanov B. U., Miller O. N., Petrova M. M., Pozdniakov Yu. M., Runikhina N. K., Saiganov S. A., Tarasov A. V., Tkacheva O. N., Urinskiy A. M., Shalnova S. A. Comorbid Pathology in Clinical Practice. ClinicalХохлова Ю. Коморбидный статус при остром коронарном синдроме // Врач. 2015. № 3. C. 19–22.Guidelines // Cardiovascular Therapy and Prevention. 2017. No. 16 (6). P. 5–56. (In Russian).Tisminetzky M., Nguyen H. L., Gurwitz J. H., McManus D., Gore J., Singh S., Yarzebski J., Goldberg R. J. Magnitude and Impact of Multiple Chronic Conditions with Advancing age in Older Adults Hospitalized with Acute Myocardial Infarction // Int J Cardiol. 2018. Vol.Vedanthan R., Seligman B., Fuster V. Global Perspective on Acute Coronary Syndrome: a Burden on the Young and Poor // Circulation Reserch. 2014. No. 114 (12). P. 1959–1975., № 272. P. 341–345.Boyd C. M., McNabney M. K., Brandt N., Correa-de-Araujuo R., Daniel M., Epplin J., Fried T. R., Goldstein M. K., Holmes H. M., Ritchie C. S., Shega J. W. Guiding PrinciplesCanivell S., Muller O., Gencer B., Heg D., Klingenberg R., Raeber L., Carballo D., Matter C. M., Luescher T. F., Windecker S., Mach F., Rodondi N., Nanchen D. Impact of Non- Cardiovascular Multimorbidity after Acute Coronary Syndrome // Eur Heart J. 2017. № 38 (1).for the Care of Older Adults with Multimorbidity: an Approach for Clinicians. American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity // J Amer Ger Soc. 2012. No. 60 (10). P. E1–E25.P. 442.Rothwell P. M. External Validity of Randomised Controlled Trials: to whom do the Results of this Trial Apply? // Lancet. 2005. No. 365. P. 82–93.Canivell S., Muller O., Gencer B., Heg D., Klingenberg R., Räber L. Prognosis of Cardiovascular and Non-Cardiovascular Multimorbidity after Acute Coronary Syndrome // РLоSEONE. 2018. № 13 (4). Р. е0195174. URL: https://journals.plos.org/ plosone/ (дата обращения: 29.04.2019).Khokhlova Yu. Comorbid Status in Acute Coronarny Syndrome // Vrach. 2015. No. 3. P. 19–22. (In Russian).Di Angelantonio E., Kaptoge S., Wormser D., Willeit P., Butterworth A. S., Bansal N. Association of Cardiometabolic Multimorbidity with Mortality // J Amer Med Assoc. 2015. № 314 (1). P. 52–60.Tisminetzky M., Nguyen H. L., Gurwitz J. H., McManus D., Gore J., Singh S., Yarzebski J., Goldberg R. J. Magnitude and Impact of Multiple Chronic Conditions with Advancing Age in Older Adults Hospitalized with Acute Myocardial Infarction // Int J Cardiol. 2018. Vol.Van den Akker M. Comorbidity or Multimorbidity: What’s in a Name? // Eur J Gen Pract. 1996. № 20. P. 65–70.1, No. 272. P. 341–345.Зыков М. В., Кашталап В. В., Быкова И. С., Герман А. И.,Canivell S., Muller O., Gencer B., Heg D., Klingenberg R., Raeber L., Carballo D., Matter C. M., Luescher T. F., Windecker S., Mach F., Rodondi N., Nanchen D. Impact of Non- Cardiovascular Multimorbidity after Acute Coronary Syndrome // Eur Heart J. 2017. No 38 (1). P. 442.Каретникова В. Н., Барбараш О. Л. Связь мультиморбидности с риском развития сердечно-сосудистых осложнений у пациентов с острым коронарным синдромом // Кардиолог. вестн. 2018.Canivell S., Muller O., Gencer B., Heg D., Klingenberg R., Räber L. Prognosis of Cardiovascular and Non-Cardiovascular Multimorbidity after Acute Coronary Syndrome // РLоSEONE. 2018. No. 13 (4): е0195174. URL: https://journals.plos.org/ plosone/article?id =Т. 13, № 2. С. 59–65.1371/journal.pone.0195174 (accessed: 29.04.2019).McManus D. D., Nguyen H. L., Saczynski J. S., Tisminetzky M., Bourell P., Goldberg R. J. Multiple Cardiovascular Comorbidities and Acute Myocardial Infarction: Temporal Trends (1990–2007) and ImpactDi Angelantonio E., Kaptoge S., Wormser D., Willeit P., Butterworth A. S., Bansal N. Association of Cardiometabolic Multimorbidity with Mortality // J Ameron Death Rates at 30 Days and 1 Year // Clinical Epidemiology. 2012. № 4. P. 115–123.Med Assoc. 2015. No. 314 (1). P. 52–60.Sanchis J., Soler M., Nunez J., Ruiz V., Bonanad C., Formiga F., Ariza-Solé A. Comorbidity Assessment for Mortality Risk Stratification in Elderly Patients with Acute Coronary Syndrome // Eur J Intern Med. 2019. № 4. P. 48–53.Van den Akker M. Comorbidity or Multimorbidity: What’s in a Name? // Eur J Gen Pract. 1996. No. 20. P. 65–70.Кожокарь К. Г., Урванцева И. А., Лифшиц Г. И., Николаев К. Ю. Ассоциации психосоциальных показателей с вероятной госпитальной летальностью по шкалам TIMI и GRACE у пациентов с острым коронарным синдромом, проживающих в условиях Севера // Клинич. практика. 2017. № 3 (31).Zykov M. V., Kashtalap V. V., Bykova I. S., German A. I., Karetnikova V. N., Barbarash O. L. Connection of Multimorbidity and Risk of Cardiovascular ComplicationsС. 18–27in Patients // Cardiologicheskiy Vestnik. 2018. No. 13 (2). P. 59–65 (in Russian).McManus D. D., Nguyen H. L., Saczynski J. S., Tisminetzky M., Bourell P., Goldberg R. J. Multiple Cardiovascular Comorbidities and Acute Myocardial Infarction: Temporal Trends (1990-2007) and Impact on Death Rates at 30 Days and 1 Year // Clinical Epidemiology. 2012. No. 4. P. 115–123.McManus D. D., Nguyen H. L., Saczynski J. S., Tisminetzky M., Bourell P., Goldberg R. J. Multiple Cardiovascular Comorbidities and Acute Myocardial Infarction: Temporal Trends (1990-2007) and Impact on Death Rates at 30 Days and 1 Year // Clinical Epidemiology. 2012. No. 4. P. 115–123.Sanchis J., Soler M., Nunez J., Ruiz V., Bonanad C., Formiga F., Ariza-Solé A. Comorbidity Assessment for Mortality Risk Stratification in Elderly Patients withSanchis J., Soler M., Nunez J., Ruiz V., Bonanad C., Formiga F., Ariza-Solé A. Comorbidity Assessment for Mortality Risk Stratification in Elderly Patients withAcute Coronary Syndrome // Eur J Intern Med. 2019. No. 4. P. 48–53.Acute Coronary Syndrome // Eur J Intern Med. 2019. No. 4. P. 48–53.Kozhokar K. G., Urvantseva I. A., Lifshits G. I., Nikolaev K. Yu. Associations of Psycosocial Indicators with Probable In-Hospital Mortality Using TIMI and GRACE Scores in Patients with Acute Coronary Syndrome Living on the North // Clinical Practice. 2017.Kozhokar K. G., Urvantseva I. A., Lifshits G. I., Nikolaev K. Yu. Associations of Psycosocial Indicators with Probable In-Hospital Mortality Using TIMI and GRACE Scores in Patients with Acute Coronary Syndrome Living on the North // Clinical Practice. 2017.No. 3 (31). P. 18–27. (In Russian).No. 3 (31). P. 18–27. (In Russian).

The authors declare that there are no conflicts of interest present.